Iratxe Macias
Barakaldo, PV, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 13, 2024
Murine Animal Models in Osteogenesis Imperfecta: The Quest for Improving the Quality of Life.
Journal: International journal of molecular sciences
Published: November 24, 2022
Educating EVs to Improve Bone Regeneration: Getting Closer to the Clinic.
Journal: International journal of molecular sciences
Published: December 20, 2021
Cutting Edge Endogenous Promoting and Exogenous Driven Strategies for Bone Regeneration.
Journal: International journal of molecular sciences
Published: June 25, 2021
Therapeutic Targeting of Fumaryl Acetoacetate Hydrolase in Hereditary Tyrosinemia Type I.
Journal: International journal of molecular sciences
Published: January 24, 2021
Crucial Role of Lamin A/C in the Migration and Differentiation of MSCs in Bone.
Journal: Cells
Published: April 29, 2020
Osteoporosis and the Potential of Cell-Based Therapeutic Strategies.
Journal: International journal of molecular sciences
Published: February 12, 2020
Hereditary tyrosinemia type I-associated mutations in fumarylacetoacetate hydrolase reduce the enzyme stability and increase its aggregation rate.
Journal: The Journal of biological chemistry
Published: May 15, 2019
Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria.
Journal: Science translational medicine
Published: March 31, 2018
Stratification and therapeutic potential of PML in metastatic breast cancer.
Journal: Nature communications
Published: October 27, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026